Elsevier Connect
News, information and features for the research, health and technology communities
News, information and features for the research, health and technology communities
Christian Marth, MD, PhD, discusses outcomes for key subgroups treated with first-line pembrolizumab and lenvatinib in advanced or recurrent endometrial cancer.
A retrospective cohort study acalabrutinib and zanubrutinib are being increasingly adopted for the treatment of CLL/SLL in the community setting.
Dr. Schiller will discuss the key clinical and pathologic features that distinguish BPDCN from other malignancies, as well as the potential differential diagnoses that share…
Researchers describe the results of using social robotics as an adjuvant therapy for hospitalized pediatric patients with cancer.
We’ve come together as a team with a shared mission: to raise essential funds for the Bladder Cancer Advocacy Network (BCAN), the nation’s only advocacy…
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD, shares post-progression and updated survival outcomes with frontline rucaparib maintenance in ovarian cancer.
An abstract is unavailable.
Randomized trials are widely recognized to play a pivotal role in the decision-making associated with the establishment of clinical guidelines.
Lova Sun, MD, MCSE, discussed genetic mutations in thyroid cancer and how they impact clinicians’ treatment options.